Barclays’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,047
| Closed | -$69.9K | – | 5334 |
|
|
2023
Q1 | $69.9K | Sell |
7,047
-10,715
| -60% | -$106K | ﹤0.01% | 4339 |
|
|
2022
Q4 | $177K | Buy |
17,762
+16,604
| +1,434% | +$124K | ﹤0.01% | 3905 |
|
|
2022
Q3 | $6K | Buy |
+1,158
| New | +$6.42K | ﹤0.01% | 4487 |
|
|
2021
Q4 | – | Sell |
-6,772
| Closed | -$61K | – | 4888 |
|
|
2021
Q3 | $61K | Buy |
6,772
+5,373
| +384% | +$46.2K | ﹤0.01% | 4069 |
|
|
2021
Q2 | $11K | Buy |
1,399
+900
| +180% | +$6.17K | ﹤0.01% | 4618 |
|
|
2021
Q1 | $3K | Buy |
+499
| New | +$2.47K | ﹤0.01% | 4543 |
|
|
2019
Q4 | – | Sell |
-146
| Closed | – | – | 6981 |
|
|
2019
Q3 | $0 | Buy |
+146
| New | +$463 | ﹤0.01% | 7278 |
|
|
2019
Q2 | – | Sell |
-353
| Closed | -$1K | – | 7410 |
|
|
2019
Q1 | $1K | Buy |
+353
| New | +$1.24K | ﹤0.01% | 6945 |
|
Barclays's APEN Position: Q2 2023 in Review
Barclays sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 7,047 shares — an estimated $69.9K sold.
Barclays first reported a position in APEN in Q1 2019 and held it in 8 quarters. The position peaked at $177K in Q4 2022. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Barclays reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Barclays sold 7,047 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $69.9K.
- Barclays first reported a position in Apollo Endosurgery, Inc. in Q1 2019 and held it in 8 quarters.
- Barclays's Apollo Endosurgery, Inc. position peaked at $177K in Q4 2022.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.